Continuous High-Dose Chlorambucil in Previously Untreated Patients with Chronic Lymphocytic Leukemia-Single-Center Experience

被引：0
|
作者：
Basic-Kinda, Sandra [1 ]
Aurer, Igor [1 ]
Dujmovic, Dino [1 ]
Radman, Ivo [1 ]
Sertic, Dubravka [1 ]
Dubravcic, Klara [2 ]
Gjadrov-Kuvezdic, Koraljka [3 ]
Batinic, Drago [2 ]
Sucic, Mirna [3 ]
Labar, Boris [1 ]
机构：
[1] Univ Hosp Ctr Zagreb, Div Hematol, Zagreb, Croatia
[2] Univ Hosp Ctr Zagreb, Dept Lab Diagnost, Zagreb, Croatia
[3] Univ Hosp Ctr Zagreb, Div Cytol, Zagreb, Croatia
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：936 / 937
页数：2
相关论文
共 50 条
  • [41] Ofatumumab combined with chlorambucil for previously untreated chronic lymphocytic leukemia: a phase I/II, open-label study in Japan
    Kiyohiko Hatake
    Michinori Ogura
    Kohichi Takada
    Masafumi Taniwaki
    Fanghong Zhang
    Taizo Fujita
    Kiyoshi Ando
    International Journal of Hematology, 2017, 106 : 240 - 247
  • [42] U.S. Food and Drug Administration Approval: Obinutuzumab in Combination with Chlorambucil for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia
    Lee, Hyon-Zu
    Miller, Barry W.
    Kwitkowski, Virginia E.
    Ricci, Stacey
    DelValle, Pedro
    Saber, Haleh
    Grillo, Joseph
    Bullock, Julie
    Florian, Jeffry
    Mehrotra, Nitin
    Ko, Chia-Wen
    Nie, Lei
    Shapiro, Marjorie
    Tolnay, Mate
    Kane, Robert C.
    Kaminskas, Edvardas
    Justice, Robert
    Farrell, Ann T.
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2014, 20 (15) : 3902 - 3907
  • [43] Ofatumumab combined with chlorambucil for previously untreated chronic lymphocytic leukemia: a phase I/II, open-label study in Japan
    Hatake, Kiyohiko
    Ogura, Michinori
    Takada, Kohichi
    Taniwaki, Masafumi
    Zhang, Fanghong
    Fujita, Taizo
    Ando, Kiyoshi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 106 (02) : 240 - 247
  • [44] Dose Intensive Rituximab and High-Dose Methylprednisolone in Elderly or Unfit Patients with Relapsed Chronic Lymphocytic Leukemia
    Pileckyte, Regina
    Valceckiene, Vilma
    Stoskus, Mindaugas
    Matuzeviciene, Reda
    Sejoniene, Jurgita
    Zvirblis, Tadas
    Griskevicius, Laimonas
    MEDICINA-LITHUANIA, 2019, 55 (11):
  • [45] Phase II study of 2-chlorodeoxyadenosine in combination with chlorambucil in previously untreated B-cell chronic lymphocytic leukemia
    Tefferi, A
    Levitt, R
    Li, CY
    Schroeder, G
    Tschetter, LK
    Michalak, JC
    Krook, JE
    Witzig, TE
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1999, 22 (05): : 509 - 516
  • [46] A phase I trial of imatinib mesylate in combination with chlorambucil in previously treated chronic lymphocytic leukemia patients
    Hebb, J. P.
    Assouline, S.
    Rousseau, C.
    Aloyz, R.
    DesJardins, P.
    Caplan, S.
    Panasci, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [47] A phase I study of imatinib mesylate in combination with chlorambucil in previously treated chronic lymphocytic leukemia patients
    Hebb, Jonathan
    Assouline, Sarit
    Rousseau, Caroline
    DesJardins, Pierre
    Caplan, Stephen
    Egorin, Merrill J.
    Amrein, Lilian
    Aloyz, Raquel
    Panasci, Lawrence
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (03) : 643 - 651
  • [48] A phase I study of imatinib mesylate in combination with chlorambucil in previously treated chronic lymphocytic leukemia patients
    Jonathan Hebb
    Sarit Assouline
    Caroline Rousseau
    Pierre DesJardins
    Stephen Caplan
    Merrill J. Egorin
    Lilian Amrein
    Raquel Aloyz
    Lawrence Panasci
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 643 - 651
  • [49] The effect of subsequent therapies in patients with chronic lymphocytic leukemia previously treated with prednisone and either cladribine or chlorambucil
    Robak, Tadeusz
    Blonski, Jerzy Z.
    Kasznicki, Marek
    Gora-Tybor, Joanna
    Dmoszynska, Anna
    Skotnicki, Aleksander
    HAEMATOLOGICA, 2005, 90 (07) : 994 - 996
  • [50] High-dose chemotherapy for chronic lymphocytic leukemia: Eligibility, timing, and benefit?
    Khouri, IF
    Keating, MJ
    ANNALS OF ONCOLOGY, 1998, 9 (02) : 131 - 132
12345